Combined Modality Therapy of Esophageal Cancer Journal Articles

abstract

• Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of patients with localized esophageal cancer. This article provides a critical review of the data on multimodality approaches to the management of esophageal cancer.

authors

• Juergens, Rosalyn
• Forastiere, Arlene

status

• published 

publication date

• October 2008

has subject area

• Adenocarcinoma (MeSH)
• Antineoplastic Combined Chemotherapy Protocols (MeSH)
• Carcinoma, Squamous Cell (MeSH)
• Combined Modality Therapy (MeSH)
• Esophageal Neoplasms (MeSH)
• Humans (MeSH)
• Neoadjuvant Therapy (MeSH)
• Neoplasm Staging (MeSH)
• Oncology & Carcinogenesis (Science Metrix)
• Survival Analysis (MeSH)
• Treatment Outcome (MeSH)

published in

• Journal of the National Comprehensive Cancer Network : JNCCN  Journal

keywords

• Adenocarcinoma
• Antineoplastic Combined Chemotherapy Protocols
• Carcinoma, Squamous Cell
• Combined Modality Therapy
• Esophageal Neoplasms
• Humans
• Neoadjuvant Therapy
• Neoplasm Staging
• Survival Analysis
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.6004/jnccn.2008.0063

PubMed ID

• 18926094

start page

• 851

end page

• 861

volume

• 6

issue

• 9